159 related articles for article (PubMed ID: 26551569)
1. Autosomal recessive hyper IgM syndrome associated with activation-induced cytidine deaminase gene in three Turkish siblings presented with tuberculosis lymphadenitis - Case report.
Patiroglu T; Akar HH; van der Burg M; Unal E
Acta Microbiol Immunol Hung; 2015 Sep; 62(3):267-74. PubMed ID: 26551569
[TBL] [Abstract][Full Text] [Related]
2. Novel mutation of the activation-induced cytidine deaminase gene in a Tajik family: special review on hyper-immunoglobulin M syndrome.
Mahdaviani SA; Hirbod-Mobarakeh A; Wang N; Aghamohammadi A; Hammarström L; Masjedi MR; Pan-Hammarström Q; Rezaei N
Expert Rev Clin Immunol; 2012 Aug; 8(6):539-46. PubMed ID: 22992148
[TBL] [Abstract][Full Text] [Related]
3. Respiratory Complications in Patients with Hyper IgM Syndrome.
Moazzami B; Yazdani R; Azizi G; Kiaei F; Tafakori M; Modaresi M; Shirzadi R; Mahdaviani SA; Sohani M; Abolhassani H; Aghamohammadi A
J Clin Immunol; 2019 Aug; 39(6):557-568. PubMed ID: 31183658
[TBL] [Abstract][Full Text] [Related]
4. A novel activation-induced cytidine deaminase (AID) mutation in Brazilian patients with hyper-IgM type 2 syndrome.
Caratão N; Cortesão CS; Reis PH; Freitas RF; Jacob CM; Pastorino AC; Carneiro-Sampaio M; Barreto VM
Clin Immunol; 2013 Aug; 148(2):279-86. PubMed ID: 23803409
[TBL] [Abstract][Full Text] [Related]
5. Novel AICDA mutation in a case of autosomal recessive hyper-IgM syndrome, growth hormone deficiency and autoimmunity.
Fazel A; Kashef S; Aleyasin S; Harsini S; Karamizadeh Z; Zoghi S; Flores SK; Boztug K; Rezaei N
Allergol Immunopathol (Madr); 2017; 45(1):82-86. PubMed ID: 27789066
[TBL] [Abstract][Full Text] [Related]
6. Genetic Analysis of Patients with Two Different Types of Hyper IgM Syndrome.
Alizadeh Z; Mazinani M; Houshmand M; Shakerian L; Nourizadeh M; Pourpak Z; Fazlollahi MR
Immunol Invest; 2018 Oct; 47(7):745-753. PubMed ID: 30081731
[TBL] [Abstract][Full Text] [Related]
7. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients.
Ouadani H; Ben-Mustapha I; Ben-ali M; Ben-khemis L; Larguèche B; Boussoffara R; Maalej S; Fetni I; Hassayoun S; Mahfoudh A; Mellouli F; Yalaoui S; Masmoudi H; Bejaoui M; Barbouche MR
Immunogenetics; 2016 Jan; 68(1):19-28. PubMed ID: 26545377
[TBL] [Abstract][Full Text] [Related]
8. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome.
Minegishi Y; Lavoie A; Cunningham-Rundles C; Bédard PM; Hébert J; Côté L; Dan K; Sedlak D; Buckley RH; Fischer A; Durandy A; Conley ME
Clin Immunol; 2000 Dec; 97(3):203-10. PubMed ID: 11112359
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of Two Rare Autosomal Recessive Disorders: Activation-Induced Cytidine Deaminase Deficiency and Sjogren-Larsson Syndrome.
Shamriz O; Molho-Pessach V; Shaag A; Daum H; Stepensky P
Isr Med Assoc J; 2016 Oct; 18(10):636-638. PubMed ID: 28471629
[No Abstract] [Full Text] [Related]
10. A novel activation-induced cytidine deaminase gene mutation in a Tunisian family with hyper IgM syndrome.
Fiorini C; Jilani S; Losi CG; Silini A; Giliani S; Ferrari S; Notarangelo LD; Plebani A; Sfar T; Helal A
Eur J Pediatr; 2004 Dec; 163(12):704-8. PubMed ID: 15372234
[TBL] [Abstract][Full Text] [Related]
11. A novel activation-induced cytidine deaminase mutation in an adult with hyper-immunoglobulin M syndrome.
Mendoza J; Quinn J; Infante A; Nath P; Amornruk N
Ann Allergy Asthma Immunol; 2021 Feb; 126(2):199-200. PubMed ID: 33127529
[No Abstract] [Full Text] [Related]
12. Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations.
Aghamohammadi A; Parvaneh N; Rezaei N; Moazzami K; Kashef S; Abolhassani H; Imanzadeh A; Mohammadi J; Hammarström L
J Clin Immunol; 2009 Nov; 29(6):769-76. PubMed ID: 19575287
[TBL] [Abstract][Full Text] [Related]
13. Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency.
Quartier P; Bustamante J; Sanal O; Plebani A; Debré M; Deville A; Litzman J; Levy J; Fermand JP; Lane P; Horneff G; Aksu G; Yalçin I; Davies G; Tezcan I; Ersoy F; Catalan N; Imai K; Fischer A; Durandy A
Clin Immunol; 2004 Jan; 110(1):22-9. PubMed ID: 14962793
[TBL] [Abstract][Full Text] [Related]
14. Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase.
Zhu Y; Nonoyama S; Morio T; Muramatsu M; Honjo T; Mizutani S
J Med Dent Sci; 2003 Mar; 50(1):41-6. PubMed ID: 12715918
[TBL] [Abstract][Full Text] [Related]
15. Clinical features and genetic analysis of Taiwanese patients with the hyper IgM syndrome phenotype.
Lee WI; Huang JL; Yeh KW; Yang MJ; Lai MC; Chen LC; Ou LS; Yao TC; Lin SJ; Jaing TH; Chen SH; Hsieh MY; Yu HH; Chien YH; Shyur SD
Pediatr Infect Dis J; 2013 Sep; 32(9):1010-6. PubMed ID: 23538518
[TBL] [Abstract][Full Text] [Related]
16. A structural basis for the biochemical behavior of activation-induced deoxycytidine deaminase class-switch recombination-defective hyper-IgM-2 mutants.
Mu Y; Prochnow C; Pham P; Chen XS; Goodman MF
J Biol Chem; 2012 Aug; 287(33):28007-16. PubMed ID: 22715099
[TBL] [Abstract][Full Text] [Related]
17. Hyper-IgM syndrome with putative dominant negative mutation in activation-induced cytidine deaminase.
Kasahara Y; Kaneko H; Fukao T; Terada T; Asano T; Kasahara K; Kondo N
J Allergy Clin Immunol; 2003 Oct; 112(4):755-60. PubMed ID: 14564357
[TBL] [Abstract][Full Text] [Related]
18. Pitfalls of "hyper"-IgM syndrome: a new CD40 ligand mutation in the presence of low IgM levels. A case report and a critical review of the literature.
Heinold A; Hanebeck B; Daniel V; Heyder J; Tran TH; Döhler B; Greil J; Müller FM
Infection; 2010 Dec; 38(6):491-6. PubMed ID: 20981468
[TBL] [Abstract][Full Text] [Related]
19. A novel mouse model for the hyper-IgM syndrome: a spontaneous activation-induced cytidine deaminase mutation leading to complete loss of Ig class switching and reduced somatic hypermutation.
Dahlberg CI; He M; Visnes T; Torres ML; Cortizas EM; Verdun RE; Westerberg LS; Severinson E; Ström L
J Immunol; 2014 Nov; 193(9):4732-8. PubMed ID: 25252954
[TBL] [Abstract][Full Text] [Related]
20. Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination.
Imai K; Catalan N; Plebani A; Maródi L; Sanal O; Kumaki S; Nagendran V; Wood P; Glastre C; Sarrot-Reynauld F; Hermine O; Forveille M; Revy P; Fischer A; Durandy A
J Clin Invest; 2003 Jul; 112(1):136-42. PubMed ID: 12840068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
